Alnylam to partner with Scangos-led biotech on infectious disease drugs

The collaboration deal was the second announced on Wednesday by Vir Biotechnology involving a Cambridge biotech.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.